New pill hopes to fight multiple cancers when other treatments fail
NCT ID NCT07252661
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests an experimental drug called ACC-1898, taken as a daily pill, in adults with advanced solid tumors (like liver, kidney, or stomach cancer) that have not responded to standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also look for signs that the drug may slow or shrink tumors. About 40 people will take part, and treatment can continue for up to two years if the cancer does not get worse and side effects are manageable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ACC-1898 (tyrosine kinase inhibitor)
- What this could lead to
- If it works, this could point toward a new treatment option for several advanced cancers that have stopped responding to other therapies.
- What could go wrong
- This is an early Phase 1 trial with only 40 participants, so it is too soon to know if ACC-1898 is safe or effective. Side effects are possible, and the drug may not shrink tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can your own immune cells beat advanced cancer?
- Can new drug cocktails reawaken the immune system against melanoma?
- Could a vaccine help fight Hard-to-Treat cancers?
- Tumor DNA mapping may unlock personalized cancer therapies